找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Global Perspectives in Ocular Oncology; Bhavna V. Chawla,Mary E. Aronow Book 2022 The Editor(s) (if applicable) and The Author(s), under e

[復(fù)制鏈接]
樓主: 爆裂
41#
發(fā)表于 2025-3-28 16:26:02 | 只看該作者
42#
發(fā)表于 2025-3-28 18:44:18 | 只看該作者
https://doi.org/10.1007/978-3-319-27853-7ncome countries (LMICs). Early detection and urgent referral to a specialized retinoblastoma treatment center is of utmost importance in order to save life, salvage the eye, and, in selected cases, retain vision. Advances in retinoblastoma screening, detection, and management in high-income countrie
43#
發(fā)表于 2025-3-29 01:23:41 | 只看該作者
44#
發(fā)表于 2025-3-29 03:46:42 | 只看該作者
45#
發(fā)表于 2025-3-29 09:17:57 | 只看該作者
https://doi.org/10.1007/978-1-4842-9568-7boplatin, etoposide, and vincristine (CEV). This regimen is efficacious when used as chemoreduction (a neoadjuvant strategy to shrink intraocular tumors) as well as in the adjuvant setting post-enucleation and to treat orbital disease when combined with surgery and radiation therapy..Concerns raised
46#
發(fā)表于 2025-3-29 12:42:05 | 只看該作者
47#
發(fā)表于 2025-3-29 18:31:03 | 只看該作者
48#
發(fā)表于 2025-3-29 20:00:11 | 只看該作者
https://doi.org/10.1007/978-3-031-31816-0c accuracy. The risk for relapse is high and relapse into the CNS can be fatal. The optimal treatment for PVRL is yet to be established. Therapeutic options are limited by drug penetration through the blood–retinal and blood–brain barriers, but different routes of delivery attempt to circumvent thes
49#
發(fā)表于 2025-3-30 00:25:22 | 只看該作者
50#
發(fā)表于 2025-3-30 04:42:07 | 只看該作者
https://doi.org/10.1007/978-0-8176-4591-5ce. The general ophthalmologist is often faced with challenges of not only diagnosing them accurately and managing them optimally, but also with inadequate knowledge and approach to genetic/systemic evaluation and counseling patient and family. This chapter addresses some of the common and infrequen
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 20:07
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
钟祥市| 寿光市| 平塘县| 宝山区| 内黄县| 通城县| 瓮安县| 霞浦县| 临夏市| 夏河县| 鄂托克旗| 永城市| 裕民县| 科技| 密云县| 宽甸| 丰宁| 高要市| 安福县| 五寨县| 山东| 龙陵县| 儋州市| 彩票| 铜鼓县| 靖远县| 广安市| 延寿县| 赤城县| 来凤县| 兴仁县| 南城县| 华坪县| 淳安县| 绥阳县| 肃南| 前郭尔| 嘉兴市| 平阳县| 西丰县| 龙山县|